A review covers the various skin manifestations seen in patients with CF, which include those related to the disease itself, and those associated with treatments for CF.
Patients with IBS-C and moderate to severe bloating achieved reductions in bloating after receiving plecanatide, but those with mild bloating showed no improvement.
The U.S. Food and Drug Administration (FDA) is gathering information on products of Indian spice makers MDH and Everest after Hong Kong halted sales of some of their.
Bristol Myers Squibb said on Thursday its experimental drug to treat Crohn's disease, a chronic inflammatory bowel condition, did not help patients achieve disease remission.